IMNM RSI Chart
Last 7 days
-10.8%
Last 30 days
-20.4%
Last 90 days
-46.5%
Trailing 12 Months
154.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 12.7M | 0 | 0 | 0 |
2023 | 4.0M | 7.3M | 10.7M | 14.0M |
2022 | 0 | 0 | 0 | 622.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Oct 02, 2023 | turner bruce | bought | 249,993 | 5.91 | 42,300 | chief strategy officer |
Oct 02, 2023 | prendergast franklyn g | acquired | - | - | 60,840 | - |
Oct 02, 2023 | siegall clay b | bought | 999,996 | 5.91 | 169,204 | president and ceo |
Oct 02, 2023 | rapp michael | acquired | 1,499,990 | 5.91 | 253,806 | - |
Jan 15, 2023 | lefenfeld michael | acquired | 55,500 | 4.00 | 13,875 | - |
Jan 15, 2023 | rapp michael | acquired | 70,000 | 4.00 | 17,500 | - |
Jan 15, 2023 | wagenheim philip | acquired | 35,000 | 4.00 | 8,750 | - |
Jan 15, 2023 | lamattina john l | acquired | 60,500 | 4.00 | 15,125 | - |
Sep 13, 2021 | rapp michael | bought | 518,202 | 19.96 | 25,962 | - |
Sep 10, 2021 | rapp michael | bought | 276,675 | 17.85 | 15,500 | - |
Which funds bought or sold IMNM recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | added | 91.13 | 3,773,710 | 4,880,890 | -% |
May 16, 2024 | COMERICA BANK | new | - | 839 | 839 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | new | - | 806,567 | 806,567 | -% |
May 15, 2024 | Prentice Capital Management, LP | sold off | -100 | -1,199,800 | - | -% |
May 15, 2024 | 683 Capital Management, LLC | sold off | -100 | -290,494 | - | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | new | - | 8,187,940 | 8,187,940 | -% |
May 15, 2024 | J. Goldman & Co LP | new | - | 1,930,150 | 1,930,150 | 0.06% |
May 15, 2024 | FARALLON CAPITAL MANAGEMENT LLC | new | - | 14,659,900 | 14,659,900 | 0.07% |
May 15, 2024 | Royal Bank of Canada | reduced | -5.31 | 374,000 | 689,000 | -% |
May 15, 2024 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | new | - | 568,405 | 568,405 | 0.01% |
Unveiling Immunome Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Immunome Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Immunome Inc News
Income Statement (Quarterly) | |||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q3 |
Revenue | -73.1% | 1,029 | 3,826 | 3,565 | 4,263 | 2,364 | 1,493 | 622 | - |
Operating Expenses | 35.4% | 133,328 | 98,479 | 8,198 | 10,036 | 6,835 | 7,787 | 8,534 | - |
S&GA Expenses | -100.0% | - | 8,040 | 4,375 | 4,320 | 2,922 | 3,535 | 3,309 | - |
R&D Expenses | 59.5% | 15,369 | 9,637 | 3,823 | 5,716 | 3,913 | 4,252 | 5,225 | - |
Interest Expenses | 39.0% | 2,807 | 2,019 | 288 | 216 | 201 | 1.00 | 1.00 | - |
Net Income | -39.8% | -129,492 | -92,634 | -4,345 | -5,557 | -4,270 | -7,786 | -8,533 | - |
Net Income Margin | -140.1% | -18.29* | -7.62* | -2.06* | -3.57* | -7.43* | -59.32* | - | - |
Free Cashflow | 25.1% | -13,334 | -17,808 | -8,650 | -6,008 | 24,067 | -6,755 | -7,571 | -8,230 |
Balance Sheet | |||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2019Q4 |
Assets | 115.3% | 320 | 149 | 93.00 | 41.00 | 48.00 | 24.00 | 31.00 | 39.00 | 48.00 | 58.00 | 63.00 | 64.00 | 43.00 | 45.00 | 12.00 | 5.00 |
Current Assets | 116.5% | 313 | 145 | 91.00 | 40.00 | 47.00 | 23.00 | 29.00 | 38.00 | 46.00 | 57.00 | 61.00 | 63.00 | 41.00 | 43.00 | 7.00 | 3.00 |
Cash Equivalents | 173.4% | 270 | 99.00 | 91.00 | 38.00 | 44.00 | 20.00 | 27.00 | 35.00 | 43.00 | 49.00 | 56.00 | 60.00 | 36.00 | 40.00 | 7.00 | 3.00 |
Net PPE | 107.5% | 4.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 |
Liabilities | 19.3% | 34.00 | 29.00 | 87.00 | 32.00 | 34.00 | 7.00 | 7.00 | 9.00 | 10.00 | 10.00 | 8.00 | 4.00 | 5.00 | 3.00 | 13.00 | 2.00 |
Current Liabilities | 41.0% | 31.00 | 22.00 | 23.00 | 26.00 | 25.00 | 7.00 | 7.00 | 9.00 | 10.00 | 10.00 | 8.00 | 4.00 | 5.00 | 3.00 | 5.00 | 2.00 |
Shareholder's Equity | 138.2% | 286 | 120 | 6.00 | 9.00 | 14.00 | 17.00 | 23.00 | 30.00 | 38.00 | 48.00 | 55.00 | 61.00 | 38.00 | 41.00 | - | - |
Retained Earnings | -58.1% | -352 | -222 | -130 | -125 | -120 | -116 | -108 | -99.68 | -90.76 | -79.10 | -71.30 | -63.50 | -58.29 | -54.39 | -50.32 | -36.60 |
Additional Paid-In Capital | 86.1% | 638 | 343 | 136 | 135 | 134 | 133 | 131 | 130 | 129 | 127 | 126 | 124 | 96.00 | 96.00 | 1.00 | 1.00 |
Shares Outstanding | 38.0% | 60.00 | 43.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 11.00 | 11.00 | 11.00 | - | - | - |
Float | - | - | - | - | 76.00 | - | - | - | 34.00 | - | - | - | 182 | - | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 |
Cashflow From Operations | 36.0% | -11,170 | -17,459 | -8,614 | -5,668 | 24,173 | -6,683 | -7,571 | -8,060 | -6,376 | -6,805 | -4,145 | -3,741 | -3,535 | -6,062 | -2,528 | -1,480 | -2,064 | - | - |
Share Based Compensation | -25.1% | 2,159 | 2,883 | 1,083 | 1,033 | 1,224 | 1,355 | 1,340 | 1,327 | 1,310 | 1,219 | 1,155 | 749 | 325 | 319 | 117 | 39.00 | 146 | - | - |
Cashflow From Investing | -24.1% | -37,231 | -30,002 | -36.00 | -340 | -106 | -72.00 | - | -170 | -6.00 | -14.00 | -26.00 | -8.00 | -31.00 | -46.00 | -124 | -361 | -55.00 | - | - |
Cashflow From Financing | 295.4% | 219,445 | 55,499 | 60,875 | - | 34.00 | - | - | - | 32.00 | -195 | 585 | 27,302 | 76.00 | 39,130 | -393 | 10,362 | 844 | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Condensed Consolidated Statements of Operations and Comprehensive Loss | ||
Collaboration revenue | $ 1,029 | $ 2,364 |
Operating expenses: | ||
In-process research and development | 111,954 | |
Research and development | 15,369 | 3,913 |
General and administrative | 6,005 | 2,922 |
Total operating expenses | 133,328 | 6,835 |
Loss from operations | (132,299) | (4,471) |
Interest income | 2,807 | 201 |
Net loss | $ (129,492) | $ (4,270) |
Per share information: | ||
Net loss per share, Basic | $ (2.51) | $ (0.35) |
Net loss per share, Diluted | $ (2.51) | $ (0.35) |
Weighted-average shares outstanding, Basic | 51,544,383 | 12,182,478 |
Weighted-average shares outstanding, Diluted | 51,544,383 | 12,182,478 |
Comprehensive loss: | ||
Net loss | $ (129,492) | $ (4,270) |
Unrealized loss on marketable securities | (18) | |
Comprehensive loss | $ (129,510) | $ (4,270) |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 269,723 | $ 98,679 |
Marketable securities | 39,983 | 39,463 |
Prepaid expenses and other current assets | 3,620 | 6,561 |
Total current assets | 313,326 | 144,703 |
Property and equipment, net | 4,302 | 2,073 |
Operating right-of-use assets | 1,458 | 1,564 |
Restricted cash | 100 | 100 |
Other long-term assets | 568 | 100 |
Total assets | 319,754 | 148,540 |
Current liabilities: | ||
Accounts payable | 7,179 | 3,311 |
Accrued expenses and other current liabilities | 10,844 | 8,025 |
Deferred revenue, current | 12,745 | 10,493 |
Total current liabilities | 30,768 | 21,829 |
Deferred revenue, non-current | 2,208 | 5,489 |
Operating lease liabilities, net of current portion | 1,206 | 1,340 |
Total liabilities | 34,182 | 28,658 |
Commitments and contingencies (Note 6) | ||
Stockholders' equity: | ||
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding at March 31, 2024 and December 31, 2023 | ||
Common stock, $0.0001 par value; 300,000,000 and 200,000,000 shares authorized at March 31, 2024 and December 31, 2023, respectively; 59,694,243 and 43,251,778 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 6 | 4 |
Additional paid-in capital | 637,861 | 342,663 |
Accumulated other comprehensive income | 4 | 22 |
Accumulated deficit | (352,299) | (222,807) |
Total stockholders' equity | 285,572 | 119,882 |
Total liabilities and stockholders' equity | $ 319,754 | $ 148,540 |